Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Polycystic Ovary Syndrome 2 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2 Recurrence 1 Multiple Myeloma 1 Leukemia, Myeloid, Chronic-Phase 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Dexamethasone 64 Cyclophosphamide 40 Bortezomib 37 Melphalan 24 Lenalidomide 23 Thalidomide 17 pomalidomide 16 fludarabine 12 daratumumab 11 carfilzomib 10 Filgrastim 8 Doxorubicin 8 Busulfan 6 Prednisone 5 Peripheral Blood Stem Cell Transplantation 5 Bendamustine Hydrochloride 5 selinexor 4 sargramostim 4 isatuximab 4 fludarabine phosphate 4 Surveys and Questionnaires 4 Etoposide 4 Clarithromycin 4 Calcium Dobesilate 4 liposomal doxorubicin 3 ixazomib 3 Radiotherapy 3 Neoadjuvant Therapy 3 Mycophenolic Acid 3 Methylprednisolone 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Multiple Myeloma × Pioglitazone × Clear all

NCT01010243 2012-05-30

MM03

University of Regensburg

Phase 1/2 Unknown

Multiple Myeloma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡